newsfilter
← Latest News
ACCESS Newswire·

NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq

ZÜRICH, SWITZERLAND / ACCESSWIRE / February 23, 2024 / NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company focused on the